These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6211994)

  • 1. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Georgotas A; Krakowski M; Gershon S
    Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline.
    Montgomery SA; Montgomery DB; McAuley R; Rani SJ; Roy D
    Adv Biochem Psychopharmacol; 1982; 32():35-42. PubMed ID: 6211942
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
    Syvälahti E; Salminen J; Lehtinen V
    J Int Med Res; 1982; 10(4):250-6. PubMed ID: 6214441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zimelidine: a second generation antidepressant. A report from the general practitioner research group.
    Practitioner; 1982 Sep; 226(1371):1625-8. PubMed ID: 6216471
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive disorder.
    Claghorn J; Gershon S; Goldstein BJ; Behrnetz S; Bush DF; Huitfeldt B
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):367-82. PubMed ID: 6225150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zimelidine: a placebo-controlled trial in depression.
    Norman TR; Burrows GD; Marriott PF; McIntyre IM; Davies BM; Moore RG
    Psychiatry Res; 1983 Feb; 8(2):95-103. PubMed ID: 6222387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double blind comparison of zimelidine and amitriptyline in endogenous depression.
    Montgomery SA; McAuley R; Rani SJ; Roy D; Montgomery DB
    Acta Psychiatr Scand Suppl; 1981; 290():314-27. PubMed ID: 6452798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open trial of zimelidine in patients with endogenous depression.
    Kiloh LG; Moore G
    Int Pharmacopsychiatry; 1982; 17(1):28-35. PubMed ID: 6211416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossover study of zimelidine and desipramine in depression: evidence for amine specificity [proceedings].
    Potter WZ; Calil HM; Extein I; Muscettola G; Goodwin FK
    Psychopharmacol Bull; 1981 Jan; 17(1):26-9. PubMed ID: 6453356
    [No Abstract]   [Full Text] [Related]  

  • 11. Zimelidine and amitriptyline in the treatment of depressive illness in general practice.
    Loudon JB; Tiplady B; Ashcroft GW; Waddell JL
    Acta Psychiatr Scand Suppl; 1981; 290():454-63. PubMed ID: 6452805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials with new bicyclic and tetracyclic compounds: zimelidine and maprotiline [proceedings].
    Claghorn JL; Mathew RJ
    Psychopharmacol Bull; 1981 Jan; 17(1):23-6. PubMed ID: 6453355
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual evoked potentials as a predictor of reported side effects during a trial of zimelidine vs. placebo in chronic pain patients.
    von Knorring L; Johansson F
    Psychiatry Res; 1979 Dec; 1(3):225-30. PubMed ID: 298350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of two new antidepressants.
    Gershon S; Georgotas A; Newton R; Bush D
    Adv Biochem Psychopharmacol; 1982; 32():57-68. PubMed ID: 6211943
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of phobic anxiety by zimelidine.
    Evans L; Moore G
    Acta Psychiatr Scand Suppl; 1981; 290():342-5. PubMed ID: 6452800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of zimelidine and desipramine in endogenous depression.
    Lingjaerde O; Bratfos O; Bratlid T; Haug JO
    Acta Psychiatr Scand; 1983 Jul; 68(1):22-30. PubMed ID: 6225313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical trial of zimelidine in depression.
    Georgotas A; Mann J; Bush D; Gershon S
    Commun Psychopharmacol; 1980; 4(1):71-7. PubMed ID: 6447007
    [No Abstract]   [Full Text] [Related]  

  • 20. A pilot study of the effect of the 5-HT-uptake inhibitor, zimelidine, on phobic anxiety.
    Koczkas S; Holmberg G; Wedin L
    Acta Psychiatr Scand Suppl; 1981; 290():328-41. PubMed ID: 6452799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.